慢性阻塞性肺病急性恶化患者的T细胞免疫状态:一个病例控制研究
Xiao-Feng Xiong1,2, Min Zhu1,2, Hong-Xia Wu1
1Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China.
Frontiers in medicine
|February 10, 2025
概括
患有COPD急性恶化 (AECOPD) 患者表现出细胞免疫抑制和T细胞功能障碍. 这项研究揭示了AECOPD期间T细胞子集的显著差异,与稳定的COPD和健康个体相比.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 细胞生物学 细胞生物学
背景情况:
- 在慢性阻塞性肺病 (COPD) 中,免疫炎症反应至关重要.
- 在COPD不同阶段的确切细胞免疫状态仍然不完全理解.
- 了解T细胞动态对于管理COPD恶化至关重要.
研究的目的:
- 在经历COPD急性恶化 (AECOPD) 和稳定COPD (SCOPD) 的患者中调查T细胞子集的分布和功能状态.
- 为了比较COPD患者的T细胞形状与健康对照 (HCs).
主要方法:
- 一项观察性病例控制研究,涉及64名AECOPD患者,43名SCOPD患者和43名HC患者.
- 用多色流细胞计分析了外围血液中T细胞子集的分布.
- 激活标记被染色以评估T细胞的功能状态.
主要成果:
- 与HC相比,AECOPD患者的淋巴细胞计数和CD4+/CD8+T细胞比率显著降低.
- 在AECOPD患者的T细胞子集中观察到HLA-DR,CD57和PD-1的升级表达.
- 与对照组相比,AECOPD患者的CD4+CD27+CD28+T细胞比例减少,CD4+CD39+和CD4+CD25+FoxP3+T细胞比例增加.
结论:
- 在AECOPD患者中发现了T细胞子集分布的显著变化.
- AECOPD与潜在的细胞免疫抑制,免疫功能障碍,异常的T细胞激活和增加的T细胞衰老有关.
- 这些发现突出了COPD不同阶段的不同免疫特征.
更多相关视频
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
Pulmonary Tuberculosis I
220
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
Pulmonary Tuberculosis III
296
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
296
Chronic Obstructive Pulmonary Disease
1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K


